| 000 | 01215 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513192704.0 | ||
| 264 | 0 | _c19991109 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0885-3185 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDamier, P | |
| 245 | 0 | 0 |
_aDyskinesias assessment in Phase II studies. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _c1999 |
||
| 300 |
_a54-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aBiological Transport _xphysiology |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Agonists _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aJaillon, C | |
| 700 | 1 | _aClavier, I | |
| 700 | 1 | _aArnulf, I | |
| 700 | 1 | _aBonnet, A M | |
| 700 | 1 | _aBejjani, B P | |
| 700 | 1 | _aAgid, Y | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 14 Suppl 1 _gp. 54-9 |
|
| 999 |
_c10450710 _d10450710 |
||